Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 24, 2015 11:39 AM ET

Life Sciences Tools and Services

Company Overview of Activiomics Limited

Company Overview

Activiomics Limited develops phosphoproteomics solutions for biomarker discovery and drug candidate profiling. It offers targeted in-depth quantification of cell signaling (TIQUAS), a phosphoproteomics technique that enables the label free quantification of phosphopeptides for biomarker discovery and drug profiling. The company’s TIQUAS platform is used to profile and cross-compare phosphopeptides. Activiomics Limited was incorporated in 2009 and is based in London, United Kingdom. As of March 4, 2014, Activiomics Limited operates as a subsidiary of Retroscreen Virology Group plc.

24 Cornhill

London,  EC3V 3ND

United Kingdom

Founded in 2009


44 84 5519 5091


44 84 5519 5092

Key Executives for Activiomics Limited

Chief Executive Officer
Scientific Founder and Founding Director
Scientific Founder and Founding Director
Principal Scientist and Project Manager
Compensation as of Fiscal Year 2014.

Activiomics Limited Key Developments

Activiomics Limited Appoints Dr. Kevin FitzGerald as CEO

Activiomics appointed Dr. Kevin FitzGerald as CEO. Dr. FitzGerald brings to the company more than 20 years’ biotechnology industry experience encompassing R&D roles at Cambridge Antibody Technology and executive leadership roles at Isogenica Ltd. (founder and CEO), Immune Targeting Systems (COO) and F-star (CEO).

Activiomics Limited Presents at Sachs Annual Biotech in Europe Investor Forum, Oct-01-2013 11:15 AM

Activiomics Limited Presents at Sachs Annual Biotech in Europe Investor Forum, Oct-01-2013 11:15 AM. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152, Zurich, Switzerland.

Activiomics Ltd. Extends Contract Research Agreement with Kyowa Hakko Kirin

Activiomics Ltd., has extended its contract research agreement with Kyowa Hakko Kirin, or KHK. The company will apply its novel TIQUAS (Targeted In-depth QUAntification of cell Signalling) phosphoproteomics platform to elucidate signalling mechanisms generated by lead compounds supplied by KHK in relevant cell-based systems. This collaboration falls within the company's' strategic partnership with BioFocus. The extension of the partnership is a strong endorsement of the quality and quantity of information that can be generated using technology platform.

Similar Private Companies By Industry

Company Name Region
Eagle Genomics Ltd Europe
Spectratox Ltd. Europe
Inpharmatica Ltd. Europe
Simbec Company Inc. Europe
DrugDev Inc. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Activiomics Limited, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at